Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Minoxidil effectively treats female pattern hair loss.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride may help some women with hair loss, but better options exist.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Mutations in certain receptors can cause diseases and offer new treatment options.